The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease

✍ Scribed by J.E. Kelsey; O. Harris; J. Cassin

• Book ID: 116285433
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 283 KB
• Volume: 203
• Category: Article
• ISSN: 0166-4328
• DOI: 10.1016/j.bbr.2009.04.035